Insider Transactions in Q4 2024 at Ocuphire Pharma, Inc. (OCUP)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2024
|
Benjamin R Yerxa President |
BUY
Open market or private purchase
|
Direct |
10,000
+2.83%
|
$0
$0.98 P/Share
|
|
Nov 18
2024
|
George Magrath Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
9,706
+1.93%
|
$9,706
$1.02 P/Share
|
|
Nov 15
2024
|
George Magrath Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
90,294
+15.74%
|
$90,294
$1.01 P/Share
|
|
Nov 07
2024
|
Benjamin R Yerxa President |
BUY
Grant, award, or other acquisition
|
Direct |
332,800
+50.0%
|
-
|
|
Nov 01
2024
|
George Magrath Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,050
-8.62%
|
$37,050
$1.18 P/Share
|
|
Oct 22
2024
|
Jean Bennett |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|